- Celiac disease is entering a new era of therapeutic innovation<p>For the ~1 in 100 people living with celiac, the burden of disease extends far beyond their plate.</p>BioPharma Dive · 1mo ago↗ source
- Planning a successful pivot from lab to clinic<p>For sterile injectables, key early decisions can have a significant impact on the products’ development.</p>BioPharma Dive · 1mo ago↗ source
- HMNC Brain Health raises $50M Series B to advance two depression drugsHMNC Brain Health has secured $50 million in a Series B fundraise designed to support two psychiatry programs into mid-stage studies. The family-owned German drugmaker Medice led the Series B, wh…Endpoints · 1mo ago↗ source